Standard v1.1 · Recorded August 2026
244 of 575 checked peptide sellers name the pharmacy that fills the order.
Peptide Alliance checks 586 US peptide sellers against eight published criteria, each checkable against the seller's own pages or a public register. The method is stated and dated, and a stranger can re-run it.
The Standard, applied to the field
- Pass
- Fail
- Not verified
Every criterion against all 586 sellers in the ledger. A census, not a score.
Findings
Sourcing guides explain seller documents, and census findings compare disclosures across the field. Every number carries its census, its denominator and its roster, generated from the ledger.
- Sourcing guide · criterion S6
Medical records and prescription transfers are different requests
Receiving a copy of a medical record does not transfer a prescription or authorize another refill. Identify the clinical record holder for the records request, and ask the pharmacies or prescriber separately about any prescription action.
Read the finding → - Sourcing guide · criterion S3
Compounded GLP-1 labels: concentration, volume and units
Syringe units, liquid volume and the amount of medication describe different things. A familiar syringe marking cannot establish a dose when the concentration or prescription has changed. Ask the dispensing pharmacist to reconcile the prescription, label and supplied syringe.
Read the finding → - Sourcing guide · criterion S4
Oral and nasal peptides: does the evidence match the product?
Evidence for a molecule does not automatically establish evidence for every product containing it. Match the exact formulation, route, strength and intended use before applying a study or an approval claim to an oral, sublingual or nasal offer.
Read the finding → - Sourcing guide · criterion S8
Drug recalls: match the product, pharmacy and lot
A recall match requires the product and identifying details in the notice, often including a lot number. A shared seller or pharmacy name alone cannot establish that a particular shipment is affected or that it is unaffected.
Read the finding → - Sourcing guide · criterion S6
Telehealth privacy: the clinic, app and data-sharing boundary
HIPAA protection depends on who holds the information and their role, not simply whether the information concerns health. A clinic’s records and information copied into a separately chosen consumer app can fall under different protections.
Read the finding → - Sourcing guide · criterion S7
Canceling telehealth: what happens to the next charge, order and refund?
Stopping future renewals, canceling an order and receiving a refund are three different outcomes. Read each condition separately before treating a monthly subscription as a flexible monthly commitment.
Read the finding →
Before starting a subscription
A monthly price does not explain when billing stops or which charges are refundable. See how to compare telehealth cancellation terms, with ElixaMD's renewal and refund disclosures as a worked example.
Newest seller records
| Seller | Kind | Criteria passed | Record |
|---|---|---|---|
| Unique Physique | Telehealth | 3 of 8 · 1 not verified | Open seller record → |
| Trimrose | Telehealth | 5 of 8 · 1 not verified | Open seller record → |
| GOAL MD | Telehealth | 4 of 8 · 1 not verified | Open seller record → |
| TRT Kingdom | Telehealth | 5 of 8 · 1 not verified | Open seller record → |
| TideMedix | Telehealth | 5 of 8 · 2 not verified | Open seller record → |
| Freeley | Telehealth | 5 of 8 | Open seller record → |
Open the full ledger, 586 sellers →
Find sellers by product
GLP-1 drugs are peptides, so their sellers sit in the same ledger as every other peptide seller.
- Semaglutide 509
- Tirzepatide 494
- Liraglutide 34
- Sermorelin 276
- NAD+ 315
- Glutathione 176
- PT-141 99
- GHK-Cu 81
- Tesamorelin 46
- BPC-157 61
- TB-500 31
- Every product →
FDA warning letters on file
A warning letter alleges violations and asks for a response. It is recorded on the seller's record and does not remove the seller from the ledger.
- Eden Health International Inc. dba Eden
- Trinity HealthCare Supply, LLC dba altRx
- OrderlyMeds LLC dba OrderlyMeds
- Maximus Health, Inc. dba Maximus
Every warning letter on file, 57 letters →
The criteria
- S1
Prescriber requirement
A licensed United States clinician evaluates each order before any drug ships. The seller states this on its own pages.
- S2
Prescription gating
The product cannot be bought without a medical evaluation. Payment alone must not produce a shipment.
- S3
Pharmacy identification
The seller names the pharmacy that fills its orders. The name must identify a real facility.
- S4
Compounding disclosure
A seller of compounded drugs says so plainly. The disclosure states that compounded products are not FDA-approved.
- S5
Analytical documentation
The seller publishes analytical evidence for what it ships. A certificate of analysis or equivalent lot documentation qualifies.
- S6
Business address
A physical United States address for the operating business is disclosed on the site.
- S7
Price disclosure
The price is published before intake or checkout begins. The number, not a starting-at tease behind a form.
- S8
Enforcement status
No FDA enforcement action has stopped the seller from operating. Any warning letter naming the entity is disclosed on its record.
Funding: how this site earns. Peptide Alliance is not a pharmacy, a prescriber, or a medical service.